Screener
AnaptysBio, Inc. ANAB Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | March 31, 2026(unaudited) | December 31, 2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000 shares authorized and no shares, issued or outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Common stock, $0.001 par value, 500,000 shares authorized, 29,031 shares and 28,019 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 29 | 28 |
| Additional paid-in capital | 838,307 | 809,765 |
| Accumulated other comprehensive loss | (146) | (24) |
| Accumulated deficit | (825,443) | (772,559) |
| Total stockholders’ equity | 12,747 | 37,210 |
| Total liabilities and stockholders’ equity | $329,684 | $364,395 |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s total equity?
- AnaptysBio, Inc. (ANAB) reported total equity of $12.75M in Q1 2026.
- How has AnaptysBio, Inc.'s total equity changed year-over-year?
- AnaptysBio, Inc.'s total equity decreased by 62.5% year-over-year, from $34.02M to $12.75M.
- What is the long-term trend for AnaptysBio, Inc.'s total equity?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s total equity has grown at a -37.7% compound annual growth rate (CAGR), from $396.73M to $37.21M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about AnaptysBio, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude